Prenetics Global Limited (PRE) Stock

Consumer Defensive · Packaged Foods · Member of Other US Stocks

Prenetics Global Limited (PRE) closed at USD 20.60 on 2026-10-14, a change of +68.4 % over the past year, with a market capitalization of USD 395.36M.

Prenetics Global Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Prenetics Global Limited key figures

Previous close

USD 20.60 (2026-10-14)

1-year change

+68.4 %

Market cap

USD 395.36M

Enterprise value

USD 221.85M

P/E ratio (trailing)

-6.54

P/E ratio (forward)

-7.74

EPS (trailing)

-3.10

EPS (forward)

-2.62

PEG ratio

n/a

Price to book

3.76

Revenue growth

210.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.46

Employees

98

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Prenetics Global Limited

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Prenetics Global Limited and compare it with other stocks.